Published in Transplantation on November 23, 2016
MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential. Curr Heart Fail Rep (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
The impact of microRNAs on protein output. Nature (2008) 32.39
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med (2005) 6.37
Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01
Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med (2013) 5.62
The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol (2002) 4.85
Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem (2009) 3.89
Foxo transcription factors control regulatory T cell development and function. Immunity (2010) 3.17
The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol (2010) 2.53
MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology (2012) 2.15
A Single miRNA-mRNA Interaction Affects the Immune Response in a Context- and Cell-Type-Specific Manner. Immunity (2015) 1.68
MicroRNAs as non-invasive biomarkers of heart transplant rejection. Eur Heart J (2014) 1.64
Advances in targeting cell surface signalling molecules for immune modulation. Nat Rev Drug Discov (2013) 1.46
Foxo in the immune system. Oncogene (2008) 1.34
T-cell costimulation and coinhibition in atherosclerosis. Circ Res (2008) 1.32
Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol (2010) 1.31
Targeted deletion of miR-182, an abundant retinal microRNA. Mol Vis (2009) 1.28
Targeting co-stimulatory pathways: transplantation and autoimmunity. Nat Rev Nephrol (2013) 1.11
miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation. PLoS Pathog (2013) 1.11
FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory. J Immunol (2013) 1.09
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients. BMC Immunol (2013) 1.03
Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner. Am J Transplant (2011) 1.02
Differential expression of microRNAs during allograft rejection. Am J Transplant (2012) 0.98
miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation (2013) 0.96
Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature (2016) 0.91
Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss. Ann N Y Acad Sci (2010) 0.87
The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept. Biologics (2007) 0.87
IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1. J Immunol (2015) 0.86
Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profiles. PLoS One (2014) 0.85
miR-182 is largely dispensable for adaptive immunity: lack of correlation between expression and function. J Immunol (2015) 0.84
MicroRNAs as master regulators of immune responses in transplant recipients. Curr Opin Organ Transplant (2015) 0.83
Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease. Adv Exp Med Biol (2008) 0.82
FOXO1 regulates dendritic cell activity through ICAM-1 and CCR7. J Immunol (2015) 0.80
Loss of miR-182 affects B-cell extrafollicular antibody response. Immunology (2016) 0.78